| Literature DB >> 27628784 |
Benjamin Balzus1, Miriam Colombo1, Fitsum Feleke Sahle1, Gaith Zoubari1, Sven Staufenbiel1, Roland Bodmeier2.
Abstract
In vitro drug release measurement is one of the most important methods used to assess the quality of a nanocarrier and estimate it́s in vivo performance. Different in vitro drug release methods have been used to investigate the drug release from nanocarriers, however, little information is available with regard to a comparison of these methods (e.g. discriminative power, reproducibility). Thus, drug release from four nanocarriers (nanocrystals, lipid nanoparticles, Eudragit® RS and ethyl cellulose nanoparticles) was investigated under sink and non-sink conditions with three drug release methods: an in situ method using Sirius® inForm and two in vitro methods using dialysis bags and Franz diffusion cells. Dexamethasone was used as the model drug. The in situ measurement was a simple and fast method but not adequately discriminating because of a too rapid drug dissolution/release. Franz diffusion cells and dialysis bags were in most cases discriminative for the different nanocarriers with the drug dissolution/release being in the order of nanocrystals>Eudragit® RS nanoparticles>lipid nanoparticles>ethyl cellulose nanoparticles. Drug release experiments with Franz diffusion cells had the highest reproducibility. The Franz diffusion cells could also be easily used with semisolid dosage forms.Entities:
Keywords: Dialysis bag; Discriminative dissolution testing; Franz diffusion cell; Skin nanocarriers; in situ drug release; in vitro drug release
Mesh:
Substances:
Year: 2016 PMID: 27628784 DOI: 10.1016/j.ijpharm.2016.09.033
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875